Acacia Pharma has a portfolio of approved and near-market products targeting large and growing markets with significant unmet medical needs.
Postoperative nausea & vomiting (PONV)
PONV is a common complication of surgery, occurring in approximately 30% of surgical patients and up to 80% of high-risk patients.
For use during invasive medical procedures, such as colonoscopy and bronchoscopy.
Chemotherapy induced nausea & vomiting (CINV)
CINV is one of the most common and feared side effects of cancer chemotherapy.
Acacia Pharma Announces Significant Continued Progress with Formulary Uptake of BARHEMSYS® and BYFAVO™ in the US
Results of Annual General Meeting
Acacia Pharma Appoints Debra Hussain as Chief Commercial Officer
View all news